139
Participants
Start Date
September 30, 2025
Primary Completion Date
May 31, 2027
Study Completion Date
May 31, 2027
Transcutaneous Oxy-Capnography
Patients will be monitored using transcutaneous oxy-capnography to evaluate the prevalence of nocturnal alveolar hypoventilation in these population. Nocturnal alveolar hypoventilation is defined with PTcCO2 \> 49 mmHg more than 10% of the time of capnographic recording.
Quality of life questionnaires
"Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, and the Patient-Reported Hypoventilation Questionnaire."
Arterial gasometry
Arterial blood gas analysis will be performed only in patients presenting nocturnal hypoventilation.
Body plethysmography
Plethysmography will be performed only in patients presenting nocturnal hypoventilation. It will be used to measure lung volume and assess pulmonary function. This non-invasive procedure involves the patient breathing into a device that measures changes in pressure within a sealed chamber.
Spirometry with reversibility test
The intervention will be performed only in patients presenting nocturnal hypoventilation. Spirometry with a reversibility test will be performed to assess lung function and evaluate the response to bronchodilators. The procedure involves measuring forced expiratory volume and forced vital capacity before and after the administration of a bronchodilator.
Clinical examination
Clinical exam will be performed only in patients presenting nocturnal hypoventilation. It will consists of standard interview/clinical examination: vital signs, cardiological, pulmonary, abdominal, neurological examination, search for clinical signs of nocturnal hypoventilation, search for signs of hypoxia/hypercapnia, pulmonary auscultation.
CHU de Toulouse Hôpital Larrey, Toulouse
Fonds de dotation Agir pour les Maladies Chroniques
UNKNOWN
University Hospital, Toulouse
OTHER